<DOC>
	<DOC>NCT01548274</DOC>
	<brief_summary>The purpose of this study is to evaluate the effects of Sarpogrelate in endothelial progenitor cells of patients with atherosclerosis.</brief_summary>
	<brief_title>Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells</brief_title>
	<detailed_description>Endothelial progenitor cells play an important role in vasculogenesis and vascular repair. Sarpogrelate, a inhibitor of HT2A, is used an an anti-platelet drug, however, a direct effect in vascular cells is supposed.</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Sarpogrelate</mesh_term>
	<criteria>Patients with atherosclerosis Patients with high risk of bleeding Patients with pregnancy Patients with allergic reaction of Salpogrelate</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>endothelial progenitor cells</keyword>
</DOC>